Indications and uses
controls the symptoms of dandruff, seborrheic dermatitis, and psoriasis.
controls the symptoms of dandruff, seborrheic dermatitis, and psoriasis.
for best results, use twice a week or as directed by a doctor. wet hair, massage onto scalp for several minutes, and then rinse. repeat if desired.
Salicylic Acid 2%
Anti-Dandruff/Anti-Seborrheic Dermatitis/Anti-Psoriasis
controls the symptoms of dandruff, seborrheic dermatitis, and psoriasis.
For external use only.
a condition that covers a large area of the body.
condition worsens or does not improve after regular use of this product as directed.
In case of accidental ingestion, get medical help or contact a Poison Control Center immediately.
Water (Aqua), Sodium Laureth Sulfate, Acrylates Crosspolymer-4, Cocamide MEA, Sodium Cocoyl Sarcosinate, Glycol Distearate, Polyquaternim-7, Fragrance (Parfum), Sodium Chloride, Sodium Hydroxide, Tetrasodium EDTA, BHT, Methylchloroisothiazolinone, Methylisothiazolinone, Blue 1 (CI 42090).
1-888-287-1915
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 49035-450-07 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-075d-f424-e053-dadaa90a57ce | DRUG FACTS |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49035-450-07 | EQUATE ANTI DANDRUFF | 207 mL in 1 BOTTLE, PLASTIC | SHAMPOO | 207 | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 49035-450 | 49035-450-07 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 535fd575-1c19-4f26-a890-c8327b31e31e | cd3dc6b0-cbbc-4a26-b2b9-666d794005d5 | 2016-02-29 | Warnings | 535fd575-1c19-4f26-a890-c8327b31e31e cd3dc6b0-cbbc-4a26-b2b9-666d794005d5 |
Adverse event summaries are temporarily unavailable. Other product information remains available.